- Home
- BCRX vs GLOB Comparison
BCRX vs GLOB Comparison
Compare BCRX & GLOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | GLOB |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1995 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BCRX | GLOB |
|---|---|---|
| Price | $8.51 | $47.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | $20.82 | ★ $79.14 |
| AVG Volume (30 Days) | ★ 4.2M | 1.7M |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | ★ 1.21 | N/A |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | $3.35 |
| Revenue Next Year | $12.55 | $5.52 |
| P/E Ratio | ★ $7.23 | $22.55 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $40.77 |
| 52 Week High | $11.31 | $142.25 |
Technical Indicators
Market Signals| Indicator | BCRX | GLOB |
|---|---|---|
| Relative Strength Index (RSI) | 63.78 | 41.31 |
| Support Level | $7.95 | $40.77 |
| Resistance Level | $8.68 | $71.47 |
| Average True Range (ATR) | 0.31 | 2.53 |
| MACD | 0.05 | 0.79 |
| Stochastic Oscillator | 70.43 | 57.19 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About GLOB Globant S.A.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.